By performing intersection analysis on 35 cervical cancer prognosis related genes and RA differential genes, a total of 3 co-upregulated differential genes were identified (Figure 5a), namely SPP1, LYZ, and MCM5, which were upregulated in patients with rheumatoid arthritis and cervical cancer. This evidence concerns the gene MCM5 and rheumatoid arthritis.